SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia

OBJECTIVE: This study aimed to explore the influence of SLC22A1, PXR, ABCG2, ABCB1 and CYP3A5*3 genetic polymorphisms on imatinib mesylate (IM) pharmacokinetics in Asian patients with chronic myeloid leukemia (CML). PATIENTS AND METHODS: Healthy subjects belonging to three Asian populations (Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Onkar, Chan, Jason Yongsheng, Lin, Keegan, Heng, Charles Chuah Thuan, Chowbay, Balram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525665/
https://www.ncbi.nlm.nih.gov/pubmed/23272163
http://dx.doi.org/10.1371/journal.pone.0051771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525665/
https://www.ncbi.nlm.nih.gov/pubmed/23272163
http://dx.doi.org/10.1371/journal.pone.0051771

Ejemplares similares